OncXerna Therapeutics

OncXerna Therapeutics is a biotech company in Waltham, United States, founded in 2018. It has raised $110.0M across 2 rounds, most recently a $30.0M Venture Round in March 2022.

Biomarker-driven oncology therapeutics

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$110.0M
Last Round
$30.0M Venture RoundMar 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

OncXerna Therapeutics is a clinical-stage oncology biopharmaceutical company developing biomarker-driven antiangiogenic therapies to treat solid tumors. The company's lead program focuses on navicixizumab, a DLL4/VEGF bispecific antibody targeting tumor angiogenesis and Notch signaling pathways. OncXerna's proprietary Xerna TME Panel is a machine learning-based tumor microenvironment classifier used to identify patients likely to respond to antiangiogenic treatment, enabling precision oncology approaches. The company has conducted Phase 1b studies in platinum-resistant ovarian cancer and other solid tumor indications. OncXerna is headquartered in Waltham, Massachusetts, and has raised over $123 million in Series C financing. The company is focused on advancing biomarker-selected patient populations to improve clinical outcomes in oncology.

Summary

It lists 11–50 employees. It has raised $110.0M in total across 2 rounds, most recently a $30.0M Venture Round in Mar 2022.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundMar 2022
$30.0M

Sign up to see all 2 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OncXerna Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/oncxerna-therapeutics"><img src="https://indexed.vc/api/badge/company/oncxerna-therapeutics" alt="OncXerna Therapeutics on Indexed.vc" width="260" height="76" /></a>